Skip to content

Comparing FARES Method With SPASO Method for Reduction of Anterior Shoulder Dislocation: a Prospective Randomized Trial

Comparing FARES Method With SPASO Method for Reduction of Anterior Shoulder Dislocation: a Prospective Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01979237
Enrollment
100
Registered
2013-11-08
Start date
2013-11-30
Completion date
Unknown
Last updated
2013-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Anterior Dislocation

Brief summary

Shoulder anterior dislocation is a major disease entity in emergency department. There are more than 10 reduction methods that have been reported. Traditional reduction methods require sedatives, which could cause adverse effects on the patients such as respiratory suppression and allergy. There are some reduction maneuvers reported recently which do not need sedatives prior to performing reduction, including FARES method and SPASO method. So far, there are no well-designed study to compare these two methods. Besides, in clinical experience, we found that combining these two methods could even get higher successful reduction rate. This study is aimed to compare these two methods as a prospective randomized design, and furthermore, to show that combining these two methods could get higher successful reduction rate.

Interventions

PROCEDURESPASO method and FARES method

SPASO method and FARES method as shoulder dislocation reduction methods

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* shoulder anterior dislocation * conscious clear * communicable

Exclusion criteria

* unconscious * non-communicable * humeral neck fracture * dislocation time \> 24 hours * neurovascular compromise

Design outcomes

Primary

MeasureTime frame
Successful reduction rateLess than 30 minutes

Countries

Taiwan

Contacts

Primary ContactShu Hao Chang, Master
aberchangtw@gmail.com886-952537691

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026